• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一致的细胞选择性模拟系列作为化学空间中的星座亮点。

Consistent Cell-selective Analog Series as Constellation Luminaries in Chemical Space.

机构信息

Department of Physicochemistry, Chemistry Institute, Universidad Nacional Autónoma de México, Avenida Universidad 3000, Mexico City, 04510, Mexico.

Department of Pharmacy, School of Chemistry, Universidad Nacional Autónoma de México, Avenida Universidad 3000, Mexico City, 04510, Mexico.

出版信息

Mol Inform. 2020 Dec;39(12):e2000061. doi: 10.1002/minf.202000061. Epub 2020 May 27.

DOI:10.1002/minf.202000061
PMID:32390313
Abstract

High-throughput screening data of compounds consistently tested against the same panel of cell lines is a rich source of information for interrogating cell-selectivity of a compound. Nevertheless, there is a high risk of false positives for these rapid-testing strategies. Then, a single cell-inactive compound can be mistakenly labeled as highly cell-selective if a false positive occurs in any of the cell assays. More interesting would be the case of a series of analogs, which are structurally related compounds, that have a trend to be active only against a small number of cells. To this end, it is herein proposed a proof-of-concept of a method for finding consistent cell-selective analog series of chemical compounds through analysis of high-throughput cell-compound screening data systematically obtained. Furthermore, statistics for quantifying cell-promiscuity and consistency of an analog series are presented.

摘要

针对同一细胞系panel 进行反复测试的化合物高通量筛选数据是探究化合物细胞选择性的丰富信息来源。然而,这些快速筛选策略存在很高的假阳性风险。如果在任何细胞测定中出现假阳性,那么单个非细胞活性化合物可能会被错误地标记为高度细胞选择性。更有趣的情况是一系列类似物,它们是结构相关的化合物,只有在少数细胞中才有活性的趋势。为此,本文提出了一种通过系统地分析高通量细胞-化合物筛选数据来寻找一致的细胞选择性类似物系列的方法的概念验证。此外,还提出了用于量化化合物混杂性和类似物系列一致性的统计方法。

相似文献

1
Consistent Cell-selective Analog Series as Constellation Luminaries in Chemical Space.一致的细胞选择性模拟系列作为化学空间中的星座亮点。
Mol Inform. 2020 Dec;39(12):e2000061. doi: 10.1002/minf.202000061. Epub 2020 May 27.
2
False positives in the early stages of drug discovery.药物发现早期的假阳性。
Curr Med Chem. 2010;17(34):4231-55. doi: 10.2174/092986710793348545.
3
Structure-Promiscuity Relationship Puzzles-Extensively Assayed Analogs with Large Differences in Target Annotations.结构-混杂性关系谜题——具有巨大靶点注释差异的广泛检测类似物
AAPS J. 2017 May;19(3):856-864. doi: 10.1208/s12248-017-0066-8. Epub 2017 Mar 6.
4
Drug-likeness and increased hydrophobicity of commercially available compound libraries for drug screening.用于药物筛选的市售化合物库的类药性和疏水性增加。
Curr Top Med Chem. 2012;12(14):1500-13. doi: 10.2174/156802612802652466.
5
Lead discovery for mammalian elongation of long chain fatty acids family 6 using a combination of high-throughput fluorescent-based assay and RapidFire mass spectrometry assay.结合基于荧光的高通量检测法和快速火焰质谱分析法进行哺乳动物长链脂肪酸延长酶家族6的先导化合物发现。
Biochem Biophys Res Commun. 2016 Nov 25;480(4):721-726. doi: 10.1016/j.bbrc.2016.10.103. Epub 2016 Oct 26.
6
Activity-aware clustering of high throughput screening data and elucidation of orthogonal structure-activity relationships.基于活性的高通量筛选数据聚类和正交构效关系解析。
J Chem Inf Model. 2011 Dec 27;51(12):3158-68. doi: 10.1021/ci2004994. Epub 2011 Dec 7.
7
Promiscuity of in Vitro Secondary Pharmacology Assays and Implications for Lead Optimization Strategies.体外二次药理学测定的混杂性及其对先导化合物优化策略的影响。
J Med Chem. 2020 Jun 25;63(12):6251-6275. doi: 10.1021/acs.jmedchem.9b01625. Epub 2019 Nov 26.
8
Profile-QSAR: a novel meta-QSAR method that combines activities across the kinase family to accurately predict affinity, selectivity, and cellular activity.谱定量构效关系(Profile-QSAR):一种新型的元定量构效关系方法,它结合了激酶家族的各项活性,可准确预测亲和力、选择性和细胞活性。
J Chem Inf Model. 2011 Aug 22;51(8):1942-56. doi: 10.1021/ci1005004. Epub 2011 Jul 19.
9
Enhancing Molecular Promiscuity Evaluation Through Assay Profiles.通过测定曲线分析增强分子混杂度评估
Pharm Res. 2018 Oct 18;35(11):240. doi: 10.1007/s11095-018-2523-1.
10
How Frequently Are Pan-Assay Interference Compounds Active? Large-Scale Analysis of Screening Data Reveals Diverse Activity Profiles, Low Global Hit Frequency, and Many Consistently Inactive Compounds.泛分析干扰化合物的出现频率有多高?大规模筛选数据的分析揭示了多样化的活性特征、低的全球命中频率以及许多始终不活跃的化合物。
J Med Chem. 2017 May 11;60(9):3879-3886. doi: 10.1021/acs.jmedchem.7b00154. Epub 2017 Apr 25.

引用本文的文献

1
DiaNat-DB: a molecular database of antidiabetic compounds from medicinal plants.DiaNat-DB:一个来自药用植物的抗糖尿病化合物分子数据库。
RSC Adv. 2021 Jan 28;11(9):5172-5178. doi: 10.1039/d0ra10453a. eCollection 2021 Jan 25.
2
Automatic Identification of Analogue Series from Large Compound Data Sets: Methods and Applications.自动识别大型化合物数据集的类似物系列:方法与应用。
Molecules. 2021 Aug 31;26(17):5291. doi: 10.3390/molecules26175291.
3
Progress on open chemoinformatic tools for expanding and exploring the chemical space.
用于拓展和探索化学空间的开放 chemoinformatic 工具的进展。
J Comput Aided Mol Des. 2022 May;36(5):341-354. doi: 10.1007/s10822-021-00399-1. Epub 2021 Jun 18.